Hang Li
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 45
- Lung Cancer Diagnosis and Treatment 23
- Ferroptosis and cancer prognosis 5
- Renal cell carcinoma treatment 4
- Co-authors
- Yuan LiYunjian PanYihua SunHaichuan HuLei ShenYang ZhangHaiquan ChenTing Ye
- Journals
- Journal of Thoracic Oncology (5 papers)OncoTargets and Therapy (5 papers)Annals of Surgical Oncology (5 papers)Clinical Cancer Research (3 papers)Lung Cancer (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hang Li
77 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 1.9k
- Cancer Research 689
- Oncology 1.2k
- Microbiology 21
- Molecular Biology 864
Countries citing papers authored by Hang Li
This map shows the geographic impact of Hang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Li more than expected).
Fields of papers citing papers by Hang Li
This network shows the impact of papers produced by Hang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Li. The network helps show where Hang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2020 | 2 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 7 | |
| 8 | 2019 | 53 | |
| 9 | 2018 | 34 | |
| 10 | 2017 | 20 | |
| 11 | 2016 | 39 | |
| 12 | 2016 | 113 | |
| 13 | 2015 | 44 | |
| 14 | 2014 | 116 | |
| 15 | 2014 | 19 | |
| 16 | 2014 | 72 | |
| 17 | 2014 | 43 | |
| 18 | 2012 | 75 | |
| 19 | 2012 | 151 | |
| 20 | 2000 | 26 |
About Hang Li
Hang Li is a scholar working on Pulmonary and Respiratory Medicine, Microbiology, Oncology, Cancer Research and Nephrology, having authored 82 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (45 papers), Lung Cancer Diagnosis and Treatment (23 papers), Lung Cancer Research Studies (17 papers), Cancer Genomics and Diagnostics (11 papers), Ferroptosis and cancer prognosis (5 papers), Renal cell carcinoma treatment (4 papers), Peptidase Inhibition and Analysis (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.9k citations), Cancer Research (689 citations), Oncology (1.2k citations), Microbiology (21 citations) and Molecular Biology (864 citations). Hang Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuan Li, Yunjian Pan, Yihua Sun, Haichuan Hu, Lei Shen, Yang Zhang, Haiquan Chen, Ting Ye, Rui Wang and Xiaoyang Luo. Their work appears in journals such as Journal of Thoracic Oncology, OncoTargets and Therapy, Annals of Surgical Oncology, Clinical Cancer Research and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.